Soluble vascular cell adhesion molecule-1 and magnesium sulfate with nifedipine treatment in Indonesian women with severe pre-eclampsia

• Published in: Interventional medicine and applied science Vol. 8; no. 3; pp. 97 - 102
• Main Authors: Pasaribu, Hotma Partogi, Hariman, Herman, Roeshadi, R Haryono, Koh, Stephen C L
• Format: Journal Article
• Language: English
• Published: Hungary Akademiai Kiado 01-09-2016; Akadémiai Kiadó
• Subjects: Cell adhesion molecules; Dosage and administration; Drug therapy; Magnesium sulfate; Nifedipine; Original Paper; Preeclampsia; Indonesia; blood pressure; nifedipine; pre-eclampsia; sVCAM-1; magnesium sulfate; normal pregnancy
• ISSN: 2061-1617; 2061-5094
• DOI: 10.1556/1646.8.2016.3.4

Endothelial cell activation in pre-eclampsia is associated with elevated soluble vascular cell adhesion molecule-1 (sVCAM-1) levels. The objective of the study was to determine whether sVCAM-1 levels in Indonesian women with pre-eclampsia were similar to other ethnic studies and to determine the effects of magnesium sulfate with nifedipine on blood pressure.
A total of 61 pregnant women were admitted, who had normal pregnancy (
 = 25) and severe pre-eclampsia (
 = 36). Blood sampling was performed at admission to the study, 1 h after placental separation, and 24 h postpartum. sVCAM-1 and blood pressure levels were determined.
The mean ages in normal pregnancy (
 = 25) and in severe pre-eclampsia (
 = 36) are 30.0 ± 3.4 years and 27.1 ± 6.1 years, respectively. Significantly elevated sVCAM-1 was seen in pre-eclampsia. No significant variation in sVCAM-1 levels during the study periods was seen in both groups of cohorts. Magnesium sulfate infusion and nifedipine significantly lowered the blood pressure level.
Elevated sVCAM-1 levels were also seen in Indonesian women with severe pre-eclampsia. The placenta may not be the only source of elevated sVCAM-1 and that endothelial dysfunction persists beyond the postpartum period. Magnesium sulfate together with nifedipine significantly lowered blood pressure. The determination of elevated sVCAM-1 in pregnancy as a risk marker for endothelial dysfunction is therefore suggested.